Profile
Full Name
Nurix Therapeutics, Inc.Ticker Symbol
NRIXExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
July 24, 2020Indexes
Not includedWebsite
http://www.nurixtx.comEmployees
286Key Details
Price
$11.56(+0.35%)
Market cap
$881.28M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$54.55M(-29.15% YoY)
Annual EPS
-$2.88(-8.68% YoY)
PE ratio
-
Next earnings date
Jul 11, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Nurix Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 9, 25 Wells Fargo
OverweightApr 9, 25 Stifel
BuyApr 9, 25 Needham
BuyApr 2, 25 HC Wainwright & Co.
BuyMar 17, 25 Leerink Partners
Market PerformFeb 3, 25 Morgan Stanley
Equal-WeightJan 29, 25 Stifel
BuyJan 29, 25 RBC Capital
OutperformJan 29, 25 Needham
BuyJan 29, 25 JP Morgan
OverweightInstitutional Ownership
- What is the ticker symbol for Nurix Therapeutics?
- Does Nurix Therapeutics pay dividends?
- What sector is Nurix Therapeutics in?
- What industry is Nurix Therapeutics in?
- What country is Nurix Therapeutics based in?
- When did Nurix Therapeutics go public?
- Is Nurix Therapeutics in the S&P 500?
- Is Nurix Therapeutics in the NASDAQ 100?
- Is Nurix Therapeutics in the Dow Jones?
- When was Nurix Therapeutics's last earnings report?
- When does Nurix Therapeutics report earnings?
- Should I buy Nurix Therapeutics stock now?
What is the ticker symbol for Nurix Therapeutics?
The ticker symbol for Nurix Therapeutics is NASDAQ:NRIX
Does Nurix Therapeutics pay dividends?
No, Nurix Therapeutics does not pay dividends
What sector is Nurix Therapeutics in?
Nurix Therapeutics is in the Healthcare sector
What industry is Nurix Therapeutics in?
Nurix Therapeutics is in the Biotechnology industry
What country is Nurix Therapeutics based in?
Nurix Therapeutics is headquartered in United States
When did Nurix Therapeutics go public?
Nurix Therapeutics's initial public offering (IPO) was on July 24, 2020
Is Nurix Therapeutics in the S&P 500?
No, Nurix Therapeutics is not included in the S&P 500 index
Is Nurix Therapeutics in the NASDAQ 100?
No, Nurix Therapeutics is not included in the NASDAQ 100 index
Is Nurix Therapeutics in the Dow Jones?
No, Nurix Therapeutics is not included in the Dow Jones index
When was Nurix Therapeutics's last earnings report?
Nurix Therapeutics's most recent earnings report was on Apr 8, 2025
When does Nurix Therapeutics report earnings?
The next expected earnings date for Nurix Therapeutics is Jul 11, 2025
Should I buy Nurix Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions